Low circulating insulin-like growth factor-1 levels are associated with high serum uric acid in nondiabetic adult subjects

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 24, Issue 12, 2014, Pages 1365-1372

  Sesti, G ^a   Hribal, M L ^a   Procopio, T ^a   Fiorentino, T V ^a   Sciacqua, A ^a   Andreozzi, F ^a   Marini, M A ^b   Perticone, F ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Cardiovascular risk; IGF 1; Uric acid

Indexed keywords

GLUCOSE BLOOD LEVEL; HUMAN GROWTH HORMONE; LIPID; SOMATOMEDIN C; URIC ACID;

ADULT; AGED; ANTHROPOMETRY; BLOOD; COHORT ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; LIVER; MALE; METABOLISM; MIDDLE AGED; RISK FACTOR; TUMOR CELL LINE;

ADULT; AGED; ANTHROPOMETRY; BLOOD GLUCOSE; CELL LINE, TUMOR; COHORT STUDIES; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LIPIDS; LIVER; MALE; MIDDLE AGED; RISK FACTORS; URIC ACID;

EID: 84919953281     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2014.06.012     Document Type: Article

References (29)

1. Succurro E., Andreozzi F., Marini M.A., Lauro R., Hribal M.L., Perticone F., et al. Low plasma insulin-like growth factor-1 levels are associated with reduced insulin sensitivity and increased insulin secretion in nondiabetic subjects. Nutr Metab Cardiovasc Dis 2009, 19:713-719.
2. Marini M.A., Succurro E., Frontoni S., Hribal M.L., Andreozzi F., Lauro R., et al. Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women. Diabetes Care 2007, 30:2145-2147.
3. Sesti G., Sciacqua A., Cardellini M., Marini M.A., Maio R., Vatrano M., et al. Plasma concentration of insulin-like growth factor-I is independently associated with insulin sensitivity in subjects with different degree of glucose tolerance. Diabetes Care 2005, 28:132-137.
4. Perticone F., Sciacqua A., Tassone E.J., Miceli S., Maio R., Addesi D., et al. One-hour post-load plasma glucose and IGF-1 in hypertensive patients. Eur J Clin Invest 2012, 42:1325-1331.
5. Arturi F., Succurro E., Procopio C., Pedace E., Mannino G.C., Lugarà M., et al. Nonalcoholic fatty liver disease is associated with low circulating levels of insulin-like growth factor-I. J Clin Endocrinol Metab 2011, 96:E1640-E1644.
6. Teppala S., Shankar A. Association between serum IGF-1 and diabetes among U.S. adults. Diabetes Care 2010, 33:2257-2259.
7. Juul A., Scheike T., Davidsen M., Gyllenborg J., Jørgensen T. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 2002, 106:939-944.
8. Facchini F., Chen Y.D., Hollenbeck C.B., Reaven G.M. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. J Am Med Assoc 1991, 266:3008-3011.
9. Choi H.K., Atkinson K., Karlson E.W., Curhan G. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med 2005, 165:742-748.
10. Perticone F., Sciacqua A., Perticone M., Arturi F., Scarpino P.E., Quero M., et al. Serum uric acid and 1-h postload glucose in essential hypertension. Diabetes Care 2012, 35:153-157.
11. Choi H.K., Ford E.S. Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med 2007, 120:442-447.
12. Kodama S., Saito K., Yachi Y., Asumi M., Sugawara A., Totsuka K., et al. Association between serum uric acid and development of type 2 diabetes. Diabetes Care 2009, 32:1737-1742.
13. Perticone F., Maio R., Tassone J.E., Perticone M., Pascale A., Sciacqua A., et al. Interaction between uric acid and endothelial dysfunction predicts new onset of diabetes in hypertensive patients. Int J Cardiol 2013, 167:232-236.
14. Verdecchia P., Schillaci G., Reboldi G., Santeusanio F., Porcellati C., Brunetti P. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study. Hypertension 2000, 36:1072-1078.
15. Hirschberg R., Kopple J.D., Blantz R.C., Tucker B.J. Effects of recombinant human insulin-like growth factor I on glomerular dynamics in the rat. J Clin Invest 1991, 87:1200-1206.
16. Baumann U., Eisenhauer T., Hartmann H. Increase of glomerular filtration rate and renal plasma flow by insulin-like growth factor-1 during euglycaemic clamping in anaesthetized rats. Eur J Clin Invest 1992, 22:204-209.
17. Tsukahara H., Gordienko D.V., Tonshoff B., Gelato M.C., Goligorsky M.S. Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells. Kidney Int 1994, 45:598-604.
18. Haylor J., Singh I., el Nahas A.M. Nitric oxide synthesis inhibitor prevents vasodilation by insulin-like growth factor I. Kidney Int 1991, 39:333-335.
19. Perticone F., Maio R., Sciacqua A., Perticone M., Laino I., Miceli S., et al. Insulin-like growth factor-1 and glomerular filtration rate in hypertensive patients. J Hypertens 2009, 27:613-617.
20. Giordano M., DeFronzo R.A. Acute effect of human recombinant insulin-like growth factor I on renal function in humans. Nephron 1995, 71:10-15.
21. Guler H.P., Schmid C., Zapf J., Froesch E.R. Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects. Proc Natl Acad Sci U S A 1989, 86:2868-2872.
22. Khosla U.M., Zharikov S., Finch J.L., Nakagawa T., Roncal C., Mu W., et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005, 67:1739-1742.
23. Corry D.B., Eslami P., Yamamoto K., Nyby M.D., Makino H., Tuck M.L. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens 2008, 26:269-275.
24. Sautin Y.Y., Nakagawa T., Zharikov S., Johnson R.J. Adverse effects of the classical antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol 2007, 293:C584-C596.
25. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26:3160-3167.
26. Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645. International Diabetes Federation Task Force on Epidemiology and Prevention, Hational Heart, Lung, and Blood InstituteHational Heart, Lung, and Blood Institute, American Heart AssociationAmerican Heart Association, World Heart FederationWorld Heart Federation, International Atherosclerosis SocietyInternational Atherosclerosis Society, International Association for the Study of ObesityInternational Association for the Study of Obesity.
27. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
28. Levey A.S., Stevens L.A., Schmid C.H., Zhang Y.L., Castro A.F., Feldman H.I., et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150:604-612. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration).
29. Kaaks R., Toniolo P., Akhmedkhanov A., Lukanova A., Biessy C., Dechaud H., et al. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 2000, 92:1592-1600.